It is a highly contagious infection that is transmitted through sexual or skin-to-skin contact.
Over three quarters of sexually active women get it at some point in their lives. Cervical cancer deaths falling in Europe Thanks in part to more widespread cervical screening and improvements in treatment, deaths from papillomavírus ist cancer have decreased over the past 30 years.
It remains the second most common cancer among women aged 15— Given the technology and development levels in papillomavírus ist Region, women have a right to be protected from this disease.
Introducing the HPV vaccine more widely, in combination with cervical screening, wp hpv nő the potential to further lower mortality rates, particularly among younger women. The vaccine is given in a three-dose series. It has a good safety profile, having been tested on tens of thousands of people before being introduced.
Since the vaccine was approved, over million doses have been distributed. Typically it is given to girls aged 11—12, as it is most effective when given before exposure to HPV: that is, before a girl becomes sexually active.
Human Papillomavirus (HPV)
Coordinated approach to cervical cancer WHO supports a comprehensive approach to papillomavírus ist, detecting and treating cervical cancer. This requires providing effective interventions to women throughout their lives, starting in childhood. These interventions include community education, social mobilization, HPV vaccination, screening, treatment and palliative care.
To achieve this, national health programmes particularly for immunization, reproductive health, cancer control and adolescent healthorganizations and partners must work together.